BG99054A - Mycobacterium vaccae for the treatment of continuous autoimmune conditions - Google Patents

Mycobacterium vaccae for the treatment of continuous autoimmune conditions

Info

Publication number
BG99054A
BG99054A BG99054A BG9905494A BG99054A BG 99054 A BG99054 A BG 99054A BG 99054 A BG99054 A BG 99054A BG 9905494 A BG9905494 A BG 9905494A BG 99054 A BG99054 A BG 99054A
Authority
BG
Bulgaria
Prior art keywords
treatment
continuous
mycobacterium vaccae
autoimmune conditions
vaccae
Prior art date
Application number
BG99054A
Other languages
Bulgarian (bg)
English (en)
Inventor
John Stanford
Graham Rook
Original Assignee
University College London
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University College London filed Critical University College London
Publication of BG99054A publication Critical patent/BG99054A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/04—Mycobacterium, e.g. Mycobacterium tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Pulmonology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • External Artificial Organs (AREA)
  • Soil Working Implements (AREA)
  • Storage Of Fruits Or Vegetables (AREA)
BG99054A 1992-02-21 1994-09-21 Mycobacterium vaccae for the treatment of continuous autoimmune conditions BG99054A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB929203814A GB9203814D0 (en) 1992-02-21 1992-02-21 Treatment of long term auto-immune conditions
PCT/GB1993/000351 WO1993016727A1 (en) 1992-02-21 1993-02-19 Mycobacterium vaccae for treatment of long term autoimmune conditions

Publications (1)

Publication Number Publication Date
BG99054A true BG99054A (en) 1995-08-28

Family

ID=10710862

Family Applications (1)

Application Number Title Priority Date Filing Date
BG99054A BG99054A (en) 1992-02-21 1994-09-21 Mycobacterium vaccae for the treatment of continuous autoimmune conditions

Country Status (24)

Country Link
US (1) US5885588A (ro)
EP (2) EP0763361B1 (ro)
JP (1) JPH07506093A (ro)
KR (1) KR100275862B1 (ro)
AT (2) ATE151641T1 (ro)
AU (2) AU675421B2 (ro)
BG (1) BG99054A (ro)
BR (1) BR9305946A (ro)
CA (1) CA2130117A1 (ro)
CZ (1) CZ282651B6 (ro)
DE (2) DE69309915T2 (ro)
DK (2) DK0763361T3 (ro)
ES (2) ES2145968T3 (ro)
FI (1) FI943849A0 (ro)
GB (1) GB9203814D0 (ro)
GR (2) GR3024113T3 (ro)
HU (1) HU218347B (ro)
NO (1) NO311169B1 (ro)
NZ (1) NZ249518A (ro)
RO (1) RO117833B1 (ro)
RU (1) RU2124367C1 (ro)
SK (1) SK99994A3 (ro)
UA (1) UA35583C2 (ro)
WO (1) WO1993016727A1 (ro)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9406301D0 (en) * 1994-03-30 1994-05-25 Univ London Immunotherapeutic agent and its use
IL110011A (en) * 1994-06-13 2004-09-27 Yeda Res & Dev Pharmacological preparations for the treatment of schizophrenia
GB9505658D0 (en) * 1995-03-21 1995-05-10 Univ London Hormone and growth factor mimetics
US6056964A (en) * 1995-03-29 2000-05-02 Stanford Rook Limited Immunotherapeutic agent and its use
US6406704B1 (en) 1996-08-29 2002-06-18 Genesis Research And Development Corporation Limited Compounds and methods for treatment and diagnosis of mycobacterial infections
US6160093A (en) * 1996-08-29 2000-12-12 Genesis Researth And Development Corporation Limited Compounds and methods for treatment and diagnosis of mycobacterial infections
US6284255B1 (en) * 1996-08-29 2001-09-04 Genesis Research & Development Corporation Limited Compounds and methods for treatment and diagnosis of mycobacterial infections
US5985287A (en) * 1996-08-29 1999-11-16 Genesis Research And Development Corporation Limited Compounds and methods for treatment and diagnosis of mycobacterial infections
AU741016B2 (en) * 1996-08-29 2001-11-22 Genesis Research And Development Corporation Limited Compounds and methods for treatment and diagnosis of mycobacterial infections
ATE307600T1 (de) * 1996-12-18 2005-11-15 Stanford Rook Ltd Verwendung von mycobacterium vaccae zur therapie des chronischen müdigkeitssyndrom
US6878377B2 (en) 1996-12-18 2005-04-12 Stanford Rook Limited Mycobacterium vaccae for down-regulation of the Th2 activity of the immune system
CA2315539A1 (en) * 1997-12-23 1999-07-01 Genesis Research & Development Corporation Limited Compositions derived from mycobacterium vaccae and methods for their use
US6328978B1 (en) 1997-12-23 2001-12-11 Genesis Research & Development Corp. Ltd. Methods for the treatment of immunologically-mediated skin disorders
US5968524A (en) * 1997-12-23 1999-10-19 Genesis Research & Development Corp. Methods and compounds for the treatment of immunologically-mediated psoriasis
US6350457B1 (en) 1999-06-02 2002-02-26 Genesis Research & Development Corporation Limited Methods and compounds for the treatment of immunologically-mediated diseases using mycobacterium vaccae
JP2003510335A (ja) * 1999-08-06 2003-03-18 コリクサ コーポレイション 自己免疫疾患の処置のためのワクチン
GB0010496D0 (en) * 2000-04-28 2000-06-14 Stanford Rook Ltd Treatment of conditions of the central nervous system
GB0106985D0 (en) * 2001-03-20 2001-05-09 Stanford Rook Ltd Immunotherapeutic agent
GB0106986D0 (en) * 2001-03-20 2001-05-09 Stanford Rook Ltd Immunotherapeutic agent
US7413728B2 (en) 2003-11-14 2008-08-19 Ucl Biomedica Plc Immune modulator

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8404280D0 (en) * 1984-02-17 1984-03-21 Stanford J L Biological preparations
IL71683A0 (en) * 1984-04-27 1984-09-30 Yeda Res & Dev Pharmaceutical compositions for treating arthritis type diseases comprising fractions obtained from mycobacteria
GB8919321D0 (en) * 1989-08-25 1989-10-11 Univ London Treatment of chronic inflammatory conditions
ATE154759T1 (de) * 1990-11-08 1997-07-15 Univ London Mycobacterium als adjuvans für antigene

Also Published As

Publication number Publication date
US5885588A (en) 1999-03-23
EP0630259A1 (en) 1994-12-28
CZ202394A3 (en) 1995-02-15
ATE151641T1 (de) 1997-05-15
GR3024113T3 (en) 1997-10-31
EP0763361A2 (en) 1997-03-19
FI943849A0 (fi) 1994-08-22
EP0763361A3 (en) 1997-03-26
JPH07506093A (ja) 1995-07-06
DE69328503T2 (de) 2000-08-24
KR100275862B1 (ko) 2000-12-15
SK99994A3 (en) 1995-05-10
NZ249518A (en) 1997-07-27
NO311169B1 (no) 2001-10-22
WO1993016727A1 (en) 1993-09-02
BR9305946A (pt) 1997-10-21
AU706122B2 (en) 1999-06-10
ES2145968T3 (es) 2000-07-16
RO117833B1 (ro) 2002-08-30
GB9203814D0 (en) 1992-04-08
GR3033772T3 (en) 2000-10-31
EP0630259B1 (en) 1997-04-16
UA35583C2 (uk) 2001-04-16
AU7188796A (en) 1997-02-06
DE69309915D1 (de) 1997-05-22
HUT69941A (en) 1995-09-28
DE69328503D1 (de) 2000-05-31
NO943082L (no) 1994-10-17
DE69309915T2 (de) 1997-07-24
ES2104131T3 (es) 1997-10-01
ATE192046T1 (de) 2000-05-15
EP0763361B1 (en) 2000-04-26
HU9402422D0 (en) 1994-10-28
CZ282651B6 (cs) 1997-08-13
NO943082D0 (no) 1994-08-22
AU3637793A (en) 1993-09-13
DK0763361T3 (da) 2000-08-07
AU675421B2 (en) 1997-02-06
KR950700755A (ko) 1995-02-20
HU218347B (hu) 2000-08-28
RU94045825A (ru) 1997-02-20
RU2124367C1 (ru) 1999-01-10
CA2130117A1 (en) 1993-09-02
DK0630259T3 (da) 1997-09-15

Similar Documents

Publication Publication Date Title
BG99054A (en) Mycobacterium vaccae for the treatment of continuous autoimmune conditions
BG107537A (en) Method for the inhibition of human tnf alpha activity and its application
ZA954679B (en) Bicyclic compounds
HUP9904665A2 (hu) Immunválaszt módosító vegyületek TH2-közvetítésű és hasonló betegségek kezelésére
UA27231C2 (uk) Застосування модафінілу як лікувального засобу, що має протиішемічну дію на церебральному рівні
KR950700333A (ko) 개량된 알파 인터페론 조성물 및 인간 말초혈 백혈구로부터의 제조 방법(improved alpha interferon composition and method for its production from human peripheral blood leukocytes)
ATE76294T1 (de) Galanthamin oder dessen analoge zur behandlung der alzheimerschen krankheit.
MY111201A (en) New imidazopyridines
GR3036691T3 (en) Dna sequences related to isolated fragile x syndrome
ES529170A0 (es) El agente antitumoral rebecamicina
KR0166663B1 (en) Use of il-10 to prevent insulin-dependent diabetes mellitus
MY104070A (en) Cyclopropane derivatives
ES2038642T3 (es) Tratamiento dermico de enfermedades vermiculares del gato con pracicuantel.
FR2689518B1 (fr) Microorganismes, procédé de préparation et utilisation.
DE3686019D1 (de) Die verwendung von nitrofurantoin zur behandlung und verhuetung von magen-darmkrankheiten.
EP0457671A3 (en) Dipyridamide for the treatment of diseases of the central or peripheral nervous system
PL334093A1 (en) Application of comt inhibitors in production of drugs preventing occurence of vascular disorders in case of diabetes
PL343758A1 (en) Purification of carboxaldehyde
GR3001850T3 (en) Expellants of phytopathogenic microbes
IE781396L (en) Purification of mercaptobenzothiazole
FR2401164A1 (fr) Nouvelles thieno-oxazines et medicament anti-allergique les contenant
DE3661822D1 (en) Alcohols and esters from the reaction of butadiene with magnesium and alkyl halogenides, their production and their use as perfumes
AU524259B2 (en) Biological treatment of sewage effluent
WO1998036758A3 (de) Sauerstoffanionradikale enthaltende therapeutische mittel und deren verwendung zur behandlung von morbus parkinson
大社淑子 Janet A. Walker: The Japanese Novel of the Meiji Period and the Ideal of Individualism Princeton University Press, 1979